Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShort-Term Debt issuancesShort-Term Debt repayments
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Change in Receivables (2020 - 2025)

Bio Essence has reported Change in Receivables over the past 6 years, most recently at $18484.0 for Q4 2025.

  • For Q4 2025, Change in Receivables rose 130.63% year-over-year to $18484.0; the TTM value through Dec 2025 reached $18329.0, up 257.71%, while the annual FY2025 figure was $18329.0, 257.71% up from the prior year.
  • Change in Receivables for Q4 2025 was $18484.0 at Bio Essence, up from -$3222.0 in the prior quarter.
  • Over five years, Change in Receivables peaked at $197295.0 in Q1 2024 and troughed at -$131825.0 in Q3 2024.
  • A 5-year average of -$67.78 and a median of $1212.0 in 2023 define the central range for Change in Receivables.
  • On a YoY basis, Change in Receivables climbed as much as 3766.26% in 2024 and fell as far as 5606.47% in 2024.
  • Year by year, Change in Receivables stood at -$4733.0 in 2021, then plummeted by 559.86% to -$31231.0 in 2022, then soared by 64.13% to -$11202.0 in 2023, then plummeted by 438.71% to -$60346.0 in 2024, then skyrocketed by 130.63% to $18484.0 in 2025.
  • Business Quant data shows Change in Receivables for BIOE at $18484.0 in Q4 2025, -$3222.0 in Q2 2025, and $3067.0 in Q1 2025.